BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 31.10.2014

Findings of Research Misconduct

Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Bijan Ahvazi, Ph.D., National Institutes of Health: Based on the report of an investigation conducted by the National Institutes of Health (NIH) and additional analysis by ORI in its oversight review, ORI found that Dr. Bijan Ahvazi, former Director of the Laboratory of X-ray Crystallography, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, engaged in research misconduct in research supported by the Intramural Program at NIAMS, NIH. ORI found that Respondent engaged in research misconduct by falsifying data related to or in the following published papers: 1. Ahvazi, B., Boeshans, K.M., Idler, W., Baxa, U., & Steinert, P.M. "Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium." J. Biol. Chem. 279(8):7180-92, 2004 Feb 20 (withdrawn) (hereinafter "JBC 2004a") 2. Ahvazi, B., Boeshans, K.M., & Steinert, P.M. "Crystal structure of transglutaminase 3 in complex with BMP: Structural basis for nucleotide specificity." J. Biol. Chem. 279:26716-25, 2004 (withdrawn) (hereinafter "JBC 20

Source: Federal Register — All DocumentsOpen original release →